D. Teegarden et al., TRANSFECTION OF C3H10T1 2 CELLS WITH THE HARVEY-RAS ONCOGENE REDUCES CYTOSOLIC PHOSPHOLIPASE A(2) FUNCTION/, Cancer letters, 107(1), 1996, pp. 59-64
Several lines of evidence suggest that phospholipase A(2) may play a r
ole in the activated ras-mediated transformation process. In the prese
nt study, phospholipase A(2) activity and expression were assessed in
a murine fibroblast cell line (C3H10T1/2 cells) that was stably transf
ected with the Harvey ras oncogene, a cellular model used for studying
multistage carcinogenesis. Reduced levels of fatty acids were release
d from the ras-transfected cells compared to untransfected controls. T
he in vitro phospholipase A(2) activity apparent in the C3H10T1/2 show
ed preference for sn-2 arachidonyl phosphatidylcholine compared to dip
almitoyl phosphatidylcholine. The activity, as well as the cytosolic p
hospholipase A(2) immunoreactive protein, was reduced by 50% in the ra
s-transfected cells compared to control cells. These results suggest t
hat the cytosolic phospholipase A(2) is the predominant form of this e
nzyme family expressed in C3H10T1/2 cells and that the activity and pr
otein amount is reduced by 50% in these cells when stably transfected
with the Harvey ras oncogene.